Table 4.
Weight loss < 5% or weight gain (n=21) | Weight loss > 5% (n=8) | p-value** (between groups) | |||||
---|---|---|---|---|---|---|---|
Week 0 | Week 24 | p-value* | Week 0 | Week 24 | p-value* | ||
NAS Score (0–8) | 4.6 (1.5) | 4.5 (2.0) | 0.90 | 4.8 (0.9) | 4.1 (1.4) | 0.28 | 0.43 |
Steatosis grade (0–3) | 1.9 (0.8) | 1.5 (0.8) | 0.05 | 2.3 (0.5) | 1.6 (0.7) | 0.049 | 0.35 |
Lobular inflammation (0–3) | 1.6 (0.7) | 1.8 (0.8) | 0.33 | 1.5 (0.5) | 1.5 (0.5) | 1.0 | 0.62 |
Hepatocyte ballooning (0–2) | 1.1 (0.8) | 1.2 (0.7) | 0.60 | 1.0 (0.8) | 1.0 (0.5) | 1.0 | 0.77 |
Data are expressed as mean with standard deviation in parentheses. Abbreviations for tables: NAS, non-alcoholic fatty liver disease activity score.
P-value between week 0 and week 24 determined with paired T-test assuming equal variance between baseline and week 24 groups.
P-value between groups represents change between week 0 and week 24 between 2 groups (group 1: weight loss < 5% or weight gain, group 2: weight loss > 5%) determined with unpaired T-test assuming equal variance between groups.